The relevance between symptoms and magnetic resonance imaging analysis of the hippocampus of depressed patients given electro-acupuncture combined with fluoxetine intervention - A randomized, controlled trial

Chinese Journal of Integrative Medicine

Volumn 17, Issue 3, 2011, Pages 190-199

  Duan, Dong Mei ^a   Tu, Ya ^b   Jiao, Shuang ^c   Qin, Wen ^d  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Depression; Electro acupuncture; Fluoxetine; Hippocampus; Magnetic resonance imaging

Indexed keywords

CHOLINE CONTAINING COMPOUND; CHOLINE DERIVATIVE; CREATINE; FLUOXETINE; N ACETYLASPARTIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; ELECTROACUPUNCTURE; FEMALE; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COMBINED MODALITY THERAPY; DEPRESSION; ELECTROACUPUNCTURE; FEMALE; FLUOXETINE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PHYSICAL EXAMINATION; PROGNOSIS; YOUNG ADULT;

EID: 79952555172     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0666-6     Document Type: Article

References (48)

1. Simon GE, Barber C, Birnbaum HG, Frank RG, Greenberg PE, Rose RM, et al. Depression and work productivity: the comparative costs of treatment versus nontreatment. J Occup Environ Med 2001;43:2-9. (Pubitemid 32098838)
2. Kessler RC, Soukup J, Davis RB, Foster Df, Wilkey SA, Van Rompay MI, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001;158:289-294. (Pubitemid 32116527)
3. Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998;10:133-147. (Pubitemid 28241361)
4. Axelson DA, Doraiswamy PM, McDonald WM, Boyko OB, Tupler LA, Patterson LJ, et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 1993;47:163-173.
5. Campbell S, Maqueen G. The role of the hippocampus in the pathophysiology of major depression. Psychiatry Neurosci 2004;29: 417-426. (Pubitemid 40075713)
6. Hashimoto K, Shimizu E, Lyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Rev 2004;45:104-114. (Pubitemid 38625738)
7. Rosso IM, Cintron CM, Steingard RJ, Renshaw PF, Young AD, Yurgelun-Todd DA. Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry 2005;57:21-26. (Pubitemid 39647587)
8. Howell LL, Wilcox KM. Functional imaging and neurochemical correlates of stimulant self administration in primates. Psychopharmacology 2002:163:352-361.
9. Zhang JB, Wang LL, Lu M, Liu LY. Li D. Effects of acupuncture at different acupoints on behaviors in depression model rats. Chin Acupunct Moxibust (Chin) 2005;25:639-643.
10. Wu MT, Hsieh JC, Xiong J, Yang CF, Pan HB, Chen YC, et al. Central nervous pathway for acupuncture stimulation:localization of processing with functional MR imaging of the brain - preliminary experience. Radiology 1999;212:133-141. (Pubitemid 29302524)
11. Lu J, Shi YJ, Jin ZX, Tu Y. Comparative study of the antidepressive effects of electroacupuncture on different frequencies in the rats. J Beijing Univ Tradit Chin Med (Chin) 2003;26(6):83-84.
12. Semple D, Smyth R, Darjee R, eds. Oxford handbook of psychiatry. Beijing: People's Medical Publishing House; 2006:22-25.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
14. Sala M, Perez J, Soloff P, Ucelli di Nemi S, Caverzasi E, Soares JC, et al. Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol 2004;14:393-405. (Pubitemid 39141682)
15. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jager M, et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 2002;159:1112-1118. (Pubitemid 34743250)
16. Shen J, Rothman DL. Magnetic resonance spectroscopic approaches to studying neuronal: Glial interactions. Biol Psychiatry 2002;52:694-700.
17. Frodl T, Schaub A, Banac S, Charypar M, Jager M, Kummler P, et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 2006;31:316-325. (Pubitemid 44497428)
18. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad USA 1996;93:3908-3913. (Pubitemid 26144221)
19. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004;161:598-607. (Pubitemid 38445502)
20. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry 2000;48:505-517.
21. Vythilingam M, Heim C, Newport J, Miller AH, Anderson E, Bronen R, et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002;159:2072-2080. (Pubitemid 35423868)
22. Lloyd AJ, Ferrier IN, Barber R, Gholkar A, Young AH, O'Brien JT. Hippocampal volume change in depression: late-and early-onset illness compared. Br J Psychiatry 2004;184:488-495. (Pubitemid 38725708)
23. Colla M, Kronenberg C, Deuschle M, Meichel K, Hagen T, Bohrer M, et al. Hippocampal volume reduction and HPA-system activity in major depression. J Psychiatr Res 2007;41:553-560. (Pubitemid 46350730)
24. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF 3rd, Becker JT. Brain morphometric abnormal i t ies in ger iat r ic depression: long- term neurobiological effects of illness duration. Am J Psychiatry 2002;159:1424-1427. (Pubitemid 34832728)
25. Shelline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160:1516-1518. (Pubitemid 41070930)
26. Yue Q, Isobe T, Shibata Y, Anno I, Kawamura H, Yamamoto Y, et al. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma. Eur Radiol 2008;18:2901-2911.
27. Mervaala E, Fohr J, Kononen M, Valkonen-Korhonen M, Vainio P, Partanen K, et al. Quantitative MRI of the hippocampus and amygdale in severe depression. Psychol Med 2000;30:117-125. (Pubitemid 30099124)
28. Lucassen PJ, Fuchs E, Czch B. Antidepressant treatment with tianeptine reduces apoptosis in hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 2004;55:789-796. (Pubitemid 38429869)
29. Rajkowska G. Depression: what we can learn from postmortem studies. Neuroscientist 2003;4:273-284. (Pubitemid 36899115)
30. Duman RS, Malberg J, Nakagawa S, D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000;48:732-739.
31. Magarinos AM, McEwen B, Flugge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 1996;15:3534-3540. (Pubitemid 26142382)
32. Cze'h B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001;98:12796-12801.
33. Moore GJ, Galloway MP. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol Bull 2002;36:5-23.
34. Jernigan TL, Archibald SL, Berhow MT, Soweel ER, Foster DS, Hesselink JR. Cerebral structure on MRI, Part I: Localization of age-related changes. Biol Psychiatry 1991;29:55-67.
35. Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000;47:1087-1090. (Pubitemid 30336218)
36. Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in affective disorders. J Neurop Psychiatry Clin Neurosci 1998;10:133-147. (Pubitemid 28241361)
37. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827. (Pubitemid 27181254)
38. Magaris AM, Deslandes A, Mcewen BS. Effect of antidepressant and benzodiazepine trentments on the dendritic structure of CA3 pyrimidal neurons after chronic stress. Eur J Pharmacol 1999;371:113-122. (Pubitemid 29216993)
39. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 2002;4:105-116. (Pubitemid 34411273)
40. Fayed N, Modrego PJ. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neurooncol 2005;72:261-265. (Pubitemid 40867410)
41. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000;48:755-765.
42. Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, et al. Characterisation of choline compounds with in vitro 1H magnetic resonance spectroscopy for discrimination of primary brain tumours. Invest Radiol 1999;34:230-235. (Pubitemid 29147057)
43. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a protonmagnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000;57:937-943.
44. Bremner JD, NarayanM, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115-118.
45. 1H-MRS in vivo. Magn Reson Med1999;41:193-197.
46. 1HNMR spectroscopy: acetylaspartate, creatine and choline. NMR Bio Med 1991;4:47-52.
47. Sapolsky RM. Stress, the aging brain, and the Mechanisms of Neuron Death. Cambridge, MA: MIT Press; 1992.
48. Pouwels PJ, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60. (Pubitemid 28028338)